13-valent pneumococcal conjugate vaccine (Wuhan BravoVax/Liaoning Cheng Da)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Name13-valent pneumococcal conjugate vaccine (Wuhan BravoVax/Liaoning Cheng Da)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMeningitisSepsisPneumonia, Bacterial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Bravovax Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Chengda Co LtdWuhan Bravovax Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningitisSepsisPneumonia, Bacterial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A